glucuronic acid has been researched along with Carcinoma, Hepatocellular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, J; Guo, B; He, G; Qi, K; Shao, M; Wang, L; Xu, X; Yang, X | 1 |
| Chen, C; Cheng, B; Gao, Q; Huang, A; Huang, L; Lei, C; Li, J; Li, X; Lin, X; Nie, D; Tang, N; Wang, K | 1 |
| Deng, F; Liu, Y; Ma, X; Sun, D; Sun, G; Wang, H; Wu, H; Zhang, Y; Zhao, S | 1 |
| Guo, H; Lai, Q; Liu, Y; Wang, W; Wu, Y; Yuan, Z; Zhang, C | 1 |
| Guo, X; Li, N; Liu, C; Liu, Y; Ma, XJ; Sun, GW; Wang, SJ; Wang, W; Xu, XX | 1 |
| Li, C; Li, J; Qian, Y; Yin, Y; Zhao, S; Zhao, Y | 1 |
| Falkenhagen, D; Harm, S; Hartmann, J; Stroble, K | 1 |
| Hang, R; Huang, X; Lin, N; Tang, B; Wang, X; Zhang, X | 1 |
| Ehmer, U; Krone, B; Manns, MP; Schütte, JK; Strassburg, CP; Vogel, A | 1 |
| Fan, ZZ; Gao, H; Gu, W; Heng, P; Li, Q; Li, XQ; Liu, XH; Sun, J | 1 |
| Cahill, PA; Halberstadt, CR; Jablonski, EM; Koniaris, LG; McKillop, IH; Moran, DM | 1 |
| Bukowski, J; Gautier, A; Kinasiewicz, A; Legallais, C; Lewinska, D; Weryński, A | 1 |
| Ma, HL; Maitani, Y; Nagai, T; Qi, XR; Xu, YF | 1 |
| Gautier, A; Kinasiewicz, A; Legallais, C; Lewiska, D; Smietanka, A; Weryński, A | 1 |
14 other study(ies) available for glucuronic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Glucuronic Acid; Humans; Liver Neoplasms; Sorafenib; Unfolded Protein Response; Uridine Diphosphate Glucose Dehydrogenase; Xenograft Model Antitumor Assays | 2022 |
Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway.
Topics: Animals; Carcinoma, Hepatocellular; Glucuronic Acid; Glutathione Transferase; Humans; Liver Neoplasms; Mice; RNA, Messenger; Transforming Growth Factor beta; Uridine Diphosphate; Uridine Diphosphate Glucose Dehydrogenase | 2022 |
Novel decellularized liver matrix-alginate hybrid gel beads for the 3D culture of hepatocellular carcinoma cells.
Topics: Alginates; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Extracellular Matrix; Gels; Glucuronic Acid; Hexuronic Acids; Humans; Liver; Liver Neoplasms; Matrix Metalloproteinases; Microspheres; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Particle Size; Phosphorylation; Spheroids, Cellular; Tissue Inhibitor of Metalloproteinases; Tissue Scaffolds; Tumor Cells, Cultured | 2018 |
Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
Topics: Alginates; Animals; Antibiotics, Antineoplastic; Area Under Curve; Carcinoma, Hepatocellular; Doxorubicin; Drug Delivery Systems; Female; Glucuronic Acid; Half-Life; Hep G2 Cells; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Microscopy, Confocal; Nanoparticles; Time Factors; Tissue Distribution | 2013 |
Encapsulated human hepatocellular carcinoma cells by alginate gel beads as an in vitro metastasis model.
Topics: Alginates; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms; Matrix Metalloproteinases; Microspheres; Models, Biological; Neoplasm Invasiveness; Transcription, Genetic; Tumor Microenvironment | 2013 |
Chemically crosslinked alginate porous microcarriers modified with bioactive molecule for expansion of human hepatocellular carcinoma cells.
Topics: Alginates; Carcinoma, Hepatocellular; Cell Proliferation; Drug Carriers; Fibroblast Growth Factor 2; Glucuronic Acid; Hep G2 Cells; Hexuronic Acids; Humans; Liver Neoplasms; Porosity | 2014 |
Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device - the hybrid-MDS.
Topics: Albumins; Alginates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chromatography, Gel; Glucose; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Liver Neoplasms; Liver, Artificial; Microscopy, Confocal; Myoglobin; Particle Size; Permeability; Polyethylenes; Polymers; Quaternary Ammonium Compounds; Regenerative Medicine; Spheroids, Cellular; Sulfonic Acids; Time Factors; Tissue Engineering; Urea | 2009 |
Matrix stiffness in three-dimensional systems effects on the behavior of C3A cells.
Topics: Albumins; Alginates; Biomarkers; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cytochrome P-450 Enzyme System; Elasticity; Gene Expression Regulation; Glucuronic Acid; Hepatocytes; Hexuronic Acids; Humans; Hydrogels; Liver Cirrhosis; Liver Neoplasms; Liver, Artificial; Mechanotransduction, Cellular; Phenotype; Time Factors | 2013 |
Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.
Topics: Adult; Aged; Aged, 80 and over; Amines; Bacterial Proteins; Carcinoma, Hepatocellular; Catalysis; Female; Genetic Predisposition to Disease; Glucuronic Acid; Glucuronosyltransferase; Humans; Liver; Liver Neoplasms; Luminescent Proteins; Male; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Steroids; Xenobiotics | 2004 |
[Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism].
Topics: Alginates; Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Proliferation; Glucuronic Acid; Hexuronic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Microspheres; Random Allocation; Rats | 2006 |
Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression.
Topics: Alginates; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Disease Progression; Drug Compounding; Drug Implants; Enzyme-Linked Immunosorbent Assay; Glucuronic Acid; Hexuronic Acids; Interleukin-6; Liver Neoplasms, Experimental; Male; Rats; Transfection | 2006 |
Culture of C3A cells in alginate beads for fluidized bed bioartificial liver.
Topics: Alginates; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms; Liver, Artificial; Serum Albumin | 2007 |
Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
Topics: Alginates; Animals; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Glucuronic Acid; Half-Life; Hexuronic Acids; Injections, Intravenous; Kupffer Cells; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Nanoparticles; Rabbits; Rats; Rats, Sprague-Dawley; Spleen; Tissue Distribution; Xenograft Model Antitumor Assays | 2008 |
Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver.
Topics: Albumins; Alginates; Biocompatible Materials; Bioreactors; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms; Liver, Artificial; Microscopy, Electron, Scanning; Microspheres; Spheroids, Cellular; Time Factors; Up-Regulation; Viscosity | 2008 |